Xanthohumol, a novel anti-HIV-1 agent purified from Hops Humulus lupulus

Antiviral Research

Volumn 64, Issue 3, 2004, Pages 189-194

  Wang, Qian ^a,c   Ding, Zhi Hui ^b   Liu, Ji Kai ^b   Zheng, Yong Tang ^a  

^a KUNMING INSTITUTE OF ZOOLOGY   (China)

^b KUNMING INSTITUTE OF BOTANY   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Anti HIV 1; Flavonoid; HIV entry; Reverse transcriptase; Xanthohumol

Indexed keywords

ANTIGEN P24; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; FLAVANOID; RNA DIRECTED DNA POLYMERASE; XANTHOHUMOL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CYTOPATHOGENIC EFFECT; CYTOTOXICITY; DRUG EFFECT; DRUG INHIBITION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMULUS LUPULUS; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS REPLICATION;

ANTI-HIV AGENTS; CELL LINE; HIV-1 REVERSE TRANSCRIPTASE; HUMULUS; PLANT EXTRACTS; PROPIOPHENONES;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMULUS; HUMULUS LUPULUS;

EID: 8644269490     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2004.08.005     Document Type: Article

References (21)

1. V.E. Buckwold, R.J.H. Wilson, A. Nalca, B.B. Beer, T.G. Voss, J.A. Yurpin, R.W. Buckheit III, J.Y. Wei, M. Wenzel-Mathers, E.M. Walton, R.J. Smith, M. Pallansch, P. Ward, J. Wells, L. Chuvala, S. Sloane, R. Paulman, J. Russell, T. Hartman, and R. Ptak Antiviral activity of hop constituents against a series of DNA and RNA viruses Antiviral Res. 61 2004 57 62
2. S.H. Chao, K. Fujinaga, J.E. Marion, R. Taube, E.A. Sausville, A.M. Senderowicz, B.M. Peterlin, and D.H. Price Flavopiridol inhibits P-TEFb and blocks HIV-1 replication J. Biol. Chem. 275 2000 28345 28348
3. J.W. Critchfield, S.T. Butera, and T.M. Folks Inhibition of HIV activation in latently infected cells by flavonoid compounds AIDS Res. Hum. Retroviruses 12 1996 39 46
4. J.W. Critchfield, J.E. Coligan, T.M. Folks, and S.T. Butera Casein kinase II is a selective target of HIV-1 transcriptional inhibitors Proc. Natl. Acad. Sci. U.S.A. 94 1997 6110 6115
5. M.R. Fesen, K.W. Kohn, F. Leteurtre, and Y. Pommier Inhibitors of human immunodeficiency virus integrase Proc. Natl. Acad. Sci. U.S.A. 90 1993 2399 2403
6. M.C. Henderson, C.L. Miranda, J.F. Stevens, M.L. Deinzer, and D.R. Buhler In vitro inhibition of human P450 enzymes by prenylated flavonoids from hops, Humulus lupulus Xenobiotica 30 2000 235 251
7. B.Q. Li, T. Fu, Y. Dongyan, J.A. Mikovits, F.W. Ruscetti, and J.M. Wang Flavonoid baicalin inhibits HIV-1 infection at the level of viral entry Biochem. Biophys. Res. Commun. 276 2000 534 538
8. Liu, J.K., Zheng, Y.T., Ding, Z.H., Wang, Q., Qu, Y., Dong, Z.J., 2002. Application and preparation of a preventive or treatment drug for HIV/AIDS. China Patent, Application No. 02113777.3, Publication No. CN 1459281 A.
9. G. Matthee, A.D. Wright, and G.M. Konig HIV reverse transcriptase inhibitors of natural origin Planta Med. 65 1999 493 506
10. C.L. Miranda, J.F. Stevens, A. Helmrich, M.C. Henderson, R.J. Rodriguez, Y.H. Yang, M.L. Deinzer, D.W. Barnes, and D.R. Buhler Antiproliferative and cytotoxic effects of prenylated flavonoids from Hop (Humulus lupulus) in human cancer cell lines Food Chem. Toxicol. 37 1999 271 285
11. C.L. Miranda, J.F. Stevens, V. Ivanov, M. McCall, B. Frei, M.L. Deinzer, and D.R. Buhler Antioxidant and prooxidant actions of prenylated and nonprenylated chalcones and flavanones in vitro J. Agric. Food Chem. 48 2000 3876 3884
12. C.L. Miranda, Y.H. Yang, M.C. Henderson, J.F. Stevens, G. Santana-Rios, M.L. Deinzer, and D.R. Buhler Prenylflavonoids from hops inhibit the metabolic activation of the carcinogenic heterocyclic amine 2-amino-3-methylimidaxo [4,5-f] quinoline, mediated by c-DNA-expressed human CYP1A2 Drug Metab. Dispos. 28 2000 1297 1302
13. M.P. Nair, C. Kandaswami, S. Mahajan, H.N. Nair, R. Chawda, T. Shanahan, and S.A. Schwartz Grape seed extract proanthocyanidins down regulate HIV-1 entry coreceptors, CCR2b, CCR3 and CCR5 gene expression by normal peripheral blood mononuclear cells Biol. Res. 35 2002 421 431
14. T.B. Ng, B. Huang, W.P. Fong, and H.W. Yeung Anti-human immunodeficiency virus (anti-HIV) natural products with special emphasis on HIV reverse transcriptase inhibitors Life Sci. 61 1997 933 949
15. M. Shimura, Y. Zhou, Y. Asada, T. Yoshikawa, K. Hatake, F. Takaku, and Y. Ishizaka Inhibition of Vpr-induced cell cycle abnormality by quercetin: a novel strategy for searching compounds targeting Vpr Biochem. Biophys. Res. Commun. 261 1999 308 316
16. S.S. Sun, W. Satoru, and S. Taiichi Chalcones from Humulus lupulus Phytochemistry 28 1989 1776 1777
17. N. Tabata, M. Ito, H. Tomoda, and S. Omura Xanthohumols, diacylglycerol acyltransferase inhibitors, from Humulus lupulus Phytochemistry 46 1997 683 687
18. A.J. Vlietinck, T. De Bruyne, S. Apers, and L.A. Pieters Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection Planta Med. 64 1998 97 109
19. J.H. Wang, H.L. Nie, S.C. Tam, H. Huang, and Y.T. Zheng Independency of anti-HIV activity from ribosome inactivating activity of trichosanthin Biochem. Biophys. Res. Commun. 302 2003 89 94
20. H.X. Xu, M. Wan, H. Dong, P.P. But, and L.Y. Foo Inhibitory activity of flavonoids and tannins against HIV-1 protease Biol. Pharm. Bull. 23 2000 1072 1076
21. Y.T. Zheng, W.F. Zhang, and K.L. Ben In vitro immunotoxicity and cytotoxicity of trichosanthin against human normal immunocytes and leukemia-lymphoma cells Immunopharmacol. Immunotoxicol. 17 1995 69 79